Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 26 Apr 2004 |
| Genmab, Capital Increase in Genmab as a Result of Employees' Warrant Exercise | 20 Apr 2004 |
| Genmab, articles of association dated April 20, 2004 | 20 Apr 2004 |
| Genmab, Passing of Genmab A/S' Annual General Meeting – Subsequent Grant of Warrants | 1 Apr 2004 |
| Genmab, articles of association dated April 1, 2004 | 1 Apr 2004 |